References
  1. Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge. American Journal of Otolaryngology. 2020;41(5):102581.
  2. Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. InMayo Clinic Proceedings 2020 Jun 6. Elsevier.
  3. Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurological Sciences. 2020 Jun 1.
  4. AlShakhs A, Almomen A, AlYaeesh I, AlOmairin A, AlMutairi AA, Alammar Z, et al. The Association of Smell and Taste Dysfunction with COVID19, And Their Functional Impacts. Indian Journal of Otolaryngology and Head & Neck Surgery. 2021 Jan 23.
  5. Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. InMayo Clinic Proceedings 2020 Jun 6. Elsevier.
  6. Mastrangelo A, Bonato M, Cinque P. Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes. Neuroscience Letters. 2021 Mar;748:135694
  7. Carrillo-Larco RM, Altez-Fernandez C. Anosmia and dysgeusia in COVID-19: A systematic review. Wellcome open research. 2020;5.
  8. Mubaraki AA, Alrbaiai GT, Sibyani AK, Alhulayfi RM, Alzaidi RS, Almalki HS. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia. Saudi Medical Journal [Internet]. 2021 Jan 1 [cited 2021 Jun 27];42(1):38â\euro“43.
  9. Elkholi SM, Abdelwahab MK, Abdelhafeez M. Impact of the smell loss on the quality of life and adopted coping strategies in COVID-19 patients. European Archives of Oto-Rhino-Laryngology. 2021 Sep;278(9):3307-14.
  10. Otte MS, Haehner A, Bork ML, Klussmann JP, Luers JC, Hummel T. Impact of COVID-19-Mediated Olfactory Loss on Quality of Life. ORL. 2022 Apr 12:1-6.
  11. Kaye R, Chang CWD, Kazahaya K, Brereton J, Denneny JC, 3rd. COVID-19 Anosmia Reporting Tool: Initial Findings. Otolaryngol Head Neck Surg. 2020;163(1):132-4.
  12. Mattos JL, Edwards C, Schlosser RJ, Hyer M, Mace JC, Smith TL, et al. A brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitis. International Forum of Allergy & Rhinology. 2019;9(10):1144-50
  13. Paderno A, Schreiber A, Grammatica A, Raffetti E, Tomasoni M, Gualtieri T et al. Smell and taste alterations in COVID‐19: a cross‐sectional analysis of different cohorts. International Forum of Allergy & Rhinology. 2020;10(8):955-962.
  14. Vaira LA, Deiana G, Fois AG, Pirina P, Madeddu G, De Vito A, Babudieri S, Petrocelli M, Serra A, Bussu F, Ligas E. Objective evaluation of anosmia and ageusia in COVID‐19 patients: single‐center experience on 72 cases. Head & neck. 2020 Jun;42(6):1252-8.
  15. Boscolo-Rizzo P, Borsetto D, Fabbris C, Spinato G, Frezza D, Menegaldo A, Mularoni F, Gaudioso P, Cazzador D, Marciani S, Frasconi S. Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngology–Head & Neck Surgery. 2020 Aug 1;146(8):729-32.
  16. Al-Ani RM, Acharya D. Prevalence of anosmia and ageusia in patients with COVID-19 at a primary health center, Doha, Qatar. Indian Journal of Otolaryngology and Head & Neck Surgery. 2020 Aug 19:1-7.
  17. Al-Rawi NH, Sammouda AR, AlRahin EA, Al Ali FA, Al Arayedh GS, Daryanavard HA, Saeed MH, Al Nuaimi AS. Prevalence of anosmia or ageusia in patients with COVID-19 among United Arab Emirates population. International Dental Journal. 2022 Apr 1;72(2):249-56.
  18. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A Human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275(43):33238–43.
  19. Sorokowski P, Karwowski M, Misiak M, Marczak MK, Dziekan M, Hummel T, Sorokowska A. Sex differences in human olfaction: a meta-analysis. Frontiers in psychology. 2019 Feb 13;10:242.
  20. Butowt R., Bilinska K., Von Bartheld C.S. Chemosensory dysfunction in COVID-19: integration of genetic and epidemiological data points to d614g spike protein variant as a contributing factor. ACS Chem Neurosci. 2020;11:3180–3184
  21. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngology–Head and Neck Surgery. 2020 Jul;163(1):3-11.
  22. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. Journal of virology. 2008 Aug 1;82(15):7264-75.
  23. Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, Zou W, Zhan J, Wang S, Xie Z, Zhuang H. Multiple organ infection and the pathogenesis of SARS. The Journal of experimental medicine. 2005 Aug 1;202(3):415-24.
  24. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. Journal of medical virology. 2020 Jun;92(6):552-5.
  25. Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, Taverner T, Chandan JS, Brown K, Simms-Williams N, Shah AD. Symptoms and risk factors for long COVID in non-hospitalized adults. Nature medicine. 2022 Aug;28(8):1706-14.
  26. Kirubhakaran K, Harshavarthanan V, Hamsavardhini Jr R, Arunkumar A, Seetharaman RR. An Analytical Study to Determine the Severity of COVID-19 Among Smokers. Cureus. 2022;14(4).
  27. Saniasiaya J, Prepageran N. Impact of olfactory dysfunction on quality of life in coronavirus disease 2019 patients: a systematic review. The Journal of Laryngology & Otology. 2021 Nov 1:1-3.
  28. Coelho DH, Reiter ER, Budd SG, Shin Y, Kons ZA, Costanzo RM. Quality of life and safety impact of COVID-19 associated smell and taste disturbances. American journal of otolaryngology. 2021 Jul 1;42(4):103001.